Table 1.
Expression of EPSPs in the N.IX-related sensory pathway.
| Area 1 (NTS) |
Area 2 (rostral medulla) |
Area 3 (pons) |
Contralateral region | ||
|---|---|---|---|---|---|
| E11 | J3269 | − | − | − | − |
| J3270 | − | − | − | − | |
| E12 | J3282 | + | − | − | − |
| J3284 | ± | ± | ± | − | |
| E13 | J3288 | ± | − | ± | − |
| J3265 | + | + | + | − | |
| J3287 | + | + | + | ± | |
| J3289 | + | + | + | ± | |
| E14 | J3357 | + | − | + | − |
| J3510 | + | + | + | ± | |
| J3345 | + | + | + | + |
The first and second columns give the embryonic day and the preparation references, respectively. The third to sixth columns show the appearance of the slow signal in Areas 1–3 and the contralateral region. “−” shows that no significant optical signal was detected (ΔI/I <1 × 10−4), “±” means that the maximum signal amplitude was ≥1 × 10−4 and <2 × 10−4, and “+” indicates that distinct optical signals (ΔI/I ≥2 × 10−4) were identified with a regional peak in each area.